AIBT OTC
Aibotics Inc.
1W: +120.0%
1M: +450.0%
3M: +214.3%
YTD: -13.7%
$0.00
+0.00 (+29.41%)
Weekly Expected Move ±56.4%
$-0
$0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Smart Money Score
No convergence signal
Key Statistics
Market Cap$1.0M
52W Range0.0003-0.0054
Volume5,657,182
Avg Volume11,083,543
Beta1.29
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOBenjamin Kaplan
Employees1
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2006-03-31
Websiteaibotics.ai
100 SE 2nd Street
Miami, FL 33131
US
Miami, FL 33131
US
954 233 3511
About Aibotics Inc.
Aibotics Inc., together with its subsidiaries, engages in the study of psychedelics for the treatment of mental health issues in the United States. It provides psychedelic methodologies for the treatment of palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| KAPLAN BENJAMIN NATH | A-Award | 75,000,000 | $0.00 | 2025-07-25 |
| Croskery Mark | A-Award | 10,000,000 | $0.01 | 2024-12-13 |
| Kaplan Benjamin | A-Award | 20,000,000 | $0.01 | 2024-12-13 |